{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:57:51Z","timestamp":1780894671765,"version":"3.54.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Post-transcriptional RNA modifications, such as N6-methyladenosine (m6A) methylation and adenosine to inosine (A-to-I) editing, are critical regulators of hematopoietic stem cell (HSC) self-renewal and differentiation, yet their precise contributions to malignant transformation are not fully elucidated. In this study, we uncovered the epitranscriptomic landscape caused by knockdown of genes from the methyltransferase (METTL)-family in hematopoietic stem and progenitor cells (HSPCs). We identified both converging and distinct effects of METTL3 and METTL14, known members of the m6A writer complex, as well as orphan gene METTL13. Amongst METTL-family members, only METTL13 transcription was increased following adenosine deaminase acting on RNA 1 (ADAR1) overexpression in HSPCs. This transcriptional pattern suggests that METTL13 may participate in biological programs that partially overlap with those controlled by the m6A writer complex and ADAR1, although any mechanistic relationship remains undefined. Knockdown of METTL13 altered the expression of multiple genes involved in oncogenic development in HSPCs. Furthermore, METTL13 expression was associated with a high-risk profile in pediatric T-cell acute lymphoblastic leukemia (T-ALL) and functional studies confirmed that METTL13 is required for T-ALL cell proliferation and survival both in vitro and in vivo. Collectively, our results identify METTL13 as a previously unrecognized regulator of leukemic transformation, independent of any presumed mechanistic interaction between RNA editing and m6A pathways.<\/jats:p>","DOI":"10.1038\/s41419-026-08761-7","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:36:05Z","timestamp":1777077365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemia"],"prefix":"10.1038","volume":"17","author":[{"given":"Sabina","family":"Enlund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Eun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adena","family":"Pepich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ramilo Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Thomsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2513-5927","authenticated-orcid":false,"given":"Indranil","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad Shirazi","family":"Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9320-7921","authenticated-orcid":false,"given":"Ola","family":"Hermanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1488-6562","authenticated-orcid":false,"given":"Frida","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"8761_CR1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20:303\u201322.","journal-title":"Nat Rev Cancer"},{"key":"8761_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41576-023-00645-2","volume":"25","author":"S Delaunay","year":"2024","unstructured":"Delaunay S, Helm M, Frye M. RNA modifications in physiology and disease: towards clinical applications. Nat Rev Genet. 2024;25:104\u201322.","journal-title":"Nat Rev Genet"},{"key":"8761_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/15476286.2021.1969113","volume":"18","author":"P Rengaraj","year":"2021","unstructured":"Rengaraj P, Obrdl\u00edk A, Vuki\u0107 D, Varadarajan NM, Keegan LP, Va\u0148\u00e1\u010dov\u00e1 \u0160, et al. Interplays of different types of epitranscriptomic mRNA modifications. RNA Biol. 2021;18:19\u201330.","journal-title":"RNA Biol"},{"key":"8761_CR4","doi-asserted-by":"publisher","first-page":"17763","DOI":"10.1073\/pnas.0903324106","volume":"106","author":"R XuFeng","year":"2009","unstructured":"XuFeng R, Boyer MJ, Shen H, Li Y, Yu H, Gao Y, et al. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc Natl Acad Sci USA. 2009;106:17763\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8761_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.exphem.2016.06.250","volume":"44","author":"BJ Liddicoat","year":"2016","unstructured":"Liddicoat BJ, Hartner JC, Piskol R, Ramaswami G, Chalk AM, Kingsley PD, et al. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis. Exp Hematol. 2016;44:947\u201363.","journal-title":"Exp Hematol"},{"key":"8761_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ccell.2018.11.017","volume":"35","author":"Jiang","year":"2019","unstructured":"Jiang, Isquith Q, Zipeto MA J, Diep RH, Pham J, Delos Santos N, et al. Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation. Cancer Cell. 2019;35:81\u201394 e87.","journal-title":"Cancer Cell"},{"key":"8761_CR7","doi-asserted-by":"publisher","first-page":"956649.","DOI":"10.3389\/fcell.2022.956649","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Wang F, Zhang Y, Liu J, Zhao B. ADAR1-Mediated RNA Editing AND Its Role in Cancer. Front Cell Devel Biol. 2022;10:956649.","journal-title":"Front Cell Devel Biol."},{"key":"8761_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.stem.2016.05.004","volume":"19","author":"MA Zipeto","year":"2016","unstructured":"Zipeto MA, Court AC, Sadarangani A, Delos Santos NP, Balaian L, Chun HJ, et al. ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. Cell Stem Cell. 2016;19:177\u201391.","journal-title":"Cell Stem Cell"},{"key":"8761_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41556-022-00959-z","volume":"24","author":"X Hao","year":"2022","unstructured":"Hao X, Shiromoto Y, Sakurai M, Towers M, Zhang Q, Wu S, et al. ADAR1 downregulation by autophagy drives senescence independently of RNA editing by enhancing p16(INK4a) levels. Nat Cell Biol. 2022;24:1202\u201310.","journal-title":"Nat Cell Biol"},{"key":"8761_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113704","volume":"43","author":"M Rivera","year":"2024","unstructured":"Rivera M, Zhang H, Pham J, Isquith J, Zhou QJ, Balaian L, et al. Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing. Cell Rep. 2024;43:113704.","journal-title":"Cell Rep"},{"key":"8761_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41586-021-03210-1","volume":"591","author":"W Xu","year":"2021","unstructured":"Xu W, Li J, He C, Wen J, Ma H, Rong B, et al. METTL3 regulates heterochromatin in mouse embryonic stem cells. Nature. 2021;591:317\u201321.","journal-title":"Nature"},{"key":"8761_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C. m(6) A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021;40:e105977.","journal-title":"EMBO J"},{"key":"8761_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transd Target Ther. 2021;6:74.","journal-title":"Signal Transd Target Ther"},{"key":"8761_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93\u201395.","journal-title":"Nat Chem Biol"},{"key":"8761_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885\u20137.","journal-title":"Nat Chem Biol"},{"key":"8761_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2020.04.009","volume":"27","author":"C Shen","year":"2020","unstructured":"Shen C, Sheng Y, Zhu AC, Robinson S, Jiang X, Dong L, et al. RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia. Cell Stem Cell. 2020;27:64\u201380.e69.","journal-title":"Cell Stem Cell"},{"key":"8761_CR17","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/1873-3468.13092","volume":"592","author":"J Mauer","year":"2018","unstructured":"Mauer J, Jaffrey SR. FTO, m(6) A(m), and the hypothesis of reversible epitranscriptomic mRNA modifications. FEBS Lett. 2018;592:2012\u201322.","journal-title":"FEBS Lett"},{"key":"8761_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18:31\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8761_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-019-1374-1","volume":"571","author":"RJ Ries","year":"2019","unstructured":"Ries RJ, Zaccara S, Klein P, Olarerin-George A, Namkoong S, Pickering BF, et al. m(6)A enhances the phase separation potential of mRNA. Nature. 2019;571:424\u20138.","journal-title":"Nature"},{"key":"8761_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nature20577","volume":"540","author":"IU Haussmann","year":"2016","unstructured":"Haussmann IU, Bodi Z, Sanchez-Moran E, Mongan NP, Archer N, Fray RG, et al. m(6)A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination. Nature. 2016;540:301\u20134.","journal-title":"Nature"},{"key":"8761_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature21022","volume":"541","author":"J Mauer","year":"2017","unstructured":"Mauer J, Luo X, Blanjoie A, Jiao X, Grozhik AV, Patil DP, et al. Reversible methylation of m(6)A(m) in the 5\u2019 cap controls mRNA stability. Nature. 2017;541:371\u20135.","journal-title":"Nature"},{"key":"8761_CR22","doi-asserted-by":"publisher","first-page":"e41576","DOI":"10.1371\/journal.pone.0041576","volume":"7","author":"R Shtrichman","year":"2012","unstructured":"Shtrichman R, Germanguz I, Mandel R, Ziskind A, Nahor I, Safran M, et al. Altered A-to-I RNA editing in human embryogenesis. PLoS ONE. 2012;7:e41576.","journal-title":"PLoS ONE"},{"key":"8761_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0370-3","volume":"13","author":"LA Crews","year":"2015","unstructured":"Crews LA, Jiang Q, Zipeto MA, Lazzari E, Court AC, Ali S, et al. An RNA editing fingerprint of cancer stem cell reprogramming. J Transl Med. 2015;13:52.","journal-title":"J Transl Med"},{"key":"8761_CR24","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.celrep.2019.07.032","volume":"28","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Luo H, Izzo F, Pickering BF, Nguyen D, Myers R, et al. m(6)A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment. Cell Rep. 2019;28:1703\u201316.e1706.","journal-title":"Cell Rep"},{"key":"8761_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature23883","volume":"549","author":"C Zhang","year":"2017","unstructured":"Zhang C, Chen Y, Sun B, Wang L, Yang Y, Ma D, et al. m(6)A modulates haematopoietic stem and progenitor cell specification. Nature. 2017;549:273\u20136.","journal-title":"Nature"},{"key":"8761_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41556-019-0318-1","volume":"21","author":"H Lee","year":"2019","unstructured":"Lee H, Bao S, Qian Y, Geula S, Leslie J, Zhang C, et al. Stage-specific requirement for Mettl3-dependent m(6)A mRNA methylation during haematopoietic stem cell differentiation. Nat Cell Biol. 2019;21:700\u20139.","journal-title":"Nat Cell Biol"},{"key":"8761_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369\u201376.","journal-title":"Nat Med"},{"key":"8761_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","volume":"20","author":"X Deng","year":"2023","unstructured":"Deng X, Qing Y, Horne D, Huang H, Chen J. The roles and implications of RNA m(6)A modification in cancer. Nat Rev Clin Oncol. 2023;20:507\u201326.","journal-title":"Nat Rev Clin Oncol"},{"key":"8761_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","volume":"54","author":"N Zhang","year":"2022","unstructured":"Zhang N, Shen Y, Li H, Chen Y, Zhang P, Lou S, et al. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. Exp Mol Med. 2022;54:194\u2013205.","journal-title":"Exp Mol Med"},{"key":"8761_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-031-45654-1_4","volume":"190","author":"M Verghese","year":"2023","unstructured":"Verghese M, Wilkinson E, He YY. Recent Advances in RNA m(6)A Modification in Solid Tumors and Tumor Immunity. Cancer Treat Res. 2023;190:95\u2013142.","journal-title":"Cancer Treat Res"},{"key":"8761_CR31","doi-asserted-by":"publisher","first-page":"45.","DOI":"10.1186\/s40164-022-00298-7","volume":"11","author":"Z Fang","year":"2022","unstructured":"Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F. et al. Role of m6A writers erasers AND readers in cancer. Exper Hematol Oncol. 2022;11:45.","journal-title":"Exper Hematol Oncol."},{"key":"8761_CR32","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1021\/acs.biochem.1c00254","volume":"60","author":"K Wang","year":"2021","unstructured":"Wang K, Peng J, Yi C. The m(6)A Consensus Motif Provides a Paradigm of Epitranscriptomic Studies. Biochemistry. 2021;60:3410\u20132.","journal-title":"Biochemistry"},{"key":"8761_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05646-y","volume":"9","author":"ME Jakobsson","year":"2018","unstructured":"Jakobsson ME, Malecki JM, Halabelian L, Nilges BS, Pinto R, Kudithipudi S, et al. The dual methyltransferase METTL13 targets N terminus and Lys55 of eEF1A and modulates codon-specific translation rates. Nat Commun. 2018;9:3411.","journal-title":"Nat Commun"},{"key":"8761_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cell.2018.11.038","volume":"176","author":"S Liu","year":"2019","unstructured":"Liu S, Hausmann S, Carlson SM, Fuentes ME, Francis JW, Pillai R, et al. METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. Cell. 2019;176:491\u2013504 e421.","journal-title":"Cell"},{"key":"8761_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12079-022-00687-x","volume":"17","author":"Q Wu","year":"2023","unstructured":"Wu Q, Hu Q, Hai Y, Li Y, Gao Y. METTL13 facilitates cell growth and metastasis in gastric cancer via an eEF1A\/HN1L positive feedback circuit. J Cell Commun Signal. 2023;17:121\u201335.","journal-title":"J Cell Commun Signal"},{"key":"8761_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02879-2","volume":"19","author":"Z Liu","year":"2021","unstructured":"Liu Z, Sun T, Piao C, Zhang Z, Kong C. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K\/AKT\/mTOR\/HIF-1alpha pathway and c-Myc expression. J Transl Med. 2021;19:209.","journal-title":"J Transl Med"},{"key":"8761_CR37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41420-025-02512-x","volume":"11","author":"K Zhao","year":"2025","unstructured":"Zhao K, Zhang H, Wang S, Zhou Y, Zhang Z, Kang B, et al. METTL13 is essential for the survival of acute myeloid leukemia cells by regulating MYC. Cell Death Discov. 2025;11:240.","journal-title":"Cell Death Discov"},{"key":"8761_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1261417","volume":"347","author":"S Geula","year":"2015","unstructured":"Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M, et al. Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science. 2015;347:1002\u20136.","journal-title":"Science"},{"key":"8761_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm3785","volume":"15","author":"KD Meyer","year":"2014","unstructured":"Meyer KD, Jaffrey SR. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014;15:313\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8761_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","volume":"33","author":"KD Meyer","year":"2017","unstructured":"Meyer KD, Jaffrey SR. Rethinking m(6)A Readers, Writers, and Erasers. Annu Rev Cell Dev Biol. 2017;33:319\u201342.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"8761_CR41","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1158\/1535-7163.MCT-23-0144","volume":"23","author":"RW Robey","year":"2024","unstructured":"Robey RW, Fitzsimmons CM, Guiblet WM, Frye WJE, Gonzalez Dalmasy JM, Wang L, et al. The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors. Mol Cancer Ther. 2024;23:464\u201377.","journal-title":"Mol Cancer Ther"},{"key":"8761_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20670-7","volume":"12","author":"E Davydova","year":"2021","unstructured":"Davydova E, Shimazu T, Schuhmacher MK, Jakobsson ME, Willemen H, Liu T, et al. The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes. Nat Commun. 2021;12:891.","journal-title":"Nat Commun"},{"key":"8761_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41556-021-00835-2","volume":"24","author":"R Su","year":"2022","unstructured":"Su R, Dong L, Li Y, Gao M, He PC, Liu W, et al. METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis. Nat Cell Biol. 2022;24:205\u201316.","journal-title":"Nat Cell Biol"},{"key":"8761_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrc991","volume":"3","author":"P Chene","year":"2003","unstructured":"Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat Rev Cancer. 2003;3:102\u20139.","journal-title":"Nat Rev Cancer"},{"key":"8761_CR45","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400\u201314.","journal-title":"Nat Rev Cancer"},{"key":"8761_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04662-7","volume":"13","author":"HJ Ha","year":"2022","unstructured":"Ha HJ, Park HH. Molecular basis of apoptotic DNA fragmentation by DFF40. Cell Death Dis. 2022;13:198.","journal-title":"Cell Death Dis"},{"key":"8761_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19:23\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"8761_CR48","doi-asserted-by":"publisher","first-page":"e3001292","DOI":"10.1371\/journal.pbio.3001292","volume":"19","author":"H Terajima","year":"2021","unstructured":"Terajima H, Lu M, Zhang L, Cui Q, Shi Y, Li J, et al. N6-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses. PLoS Biol. 2021;19:e3001292.","journal-title":"PLoS Biol"},{"key":"8761_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","volume":"23","author":"G van Loo","year":"2023","unstructured":"van Loo G, Bertrand MJM. Death by TNF: a road to inflammation. Nat Rev Immunol. 2023;23:289\u2013303.","journal-title":"Nat Rev Immunol"},{"key":"8761_CR50","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/ni.3503","volume":"17","author":"NC Di Paolo","year":"2016","unstructured":"Di Paolo NC, Shayakhmetov DM. Interleukin 1alpha and the inflammatory process. Nat Immunol. 2016;17:906\u201313.","journal-title":"Nat Immunol"},{"key":"8761_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier S, Gouwy M, Proost P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol. 2023;20:217\u201351.","journal-title":"Cell Mol Immunol"},{"key":"8761_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1173467","volume":"13","author":"A Qin","year":"2023","unstructured":"Qin A. An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1. Front Oncol. 2023;13:1173467.","journal-title":"Front Oncol"},{"key":"8761_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13046-021-02215-y","volume":"41","author":"T Flieswasser","year":"2022","unstructured":"Flieswasser T, Van den Eynde A, Van Audenaerde J, De Waele J, Lardon F, Riether C, et al. The CD70-CD27 axis in oncology: the new kids on the block. J Exp Clin Cancer Res. 2022;41:12.","journal-title":"J Exp Clin Cancer Res"},{"key":"8761_CR54","doi-asserted-by":"publisher","first-page":"27.","DOI":"10.3892\/ijo.2024.5615","volume":"64","author":"G Wu","year":"2024","unstructured":"Wu G, Wang D, Xiong F, Wang Q, Liu W, Chen J, et al. The emerging roles of CEACAM6 in human cancer (Review). Int J Oncol. 2024;6427.","journal-title":"Int J Oncol."},{"key":"8761_CR55","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature25795","volume":"555","author":"X Ma","year":"2018","unstructured":"Ma X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature. 2018;555:371\u20136.","journal-title":"Nature"},{"key":"8761_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/07853890.2018.1564359","volume":"51","author":"W Zhang","year":"2019","unstructured":"Zhang W, Kuang P, Liu T. Prognostic significance of CDKN2A\/B deletions in acute lymphoblastic leukaemia: a meta-analysis. Ann Med. 2019;51:28\u201340.","journal-title":"Ann Med"},{"key":"8761_CR57","doi-asserted-by":"publisher","first-page":"938.","DOI":"10.3390\/medicina59050938","volume":"59","author":"P Radu","year":"2023","unstructured":"Radu P, Zurzu M, Paic V, Bratucu M, Garofil D, Tigora A, et al. CD34-structure functions AND relationship with cancer stem cells. Medicina. 2023;59:938.","journal-title":"Medicina."},{"key":"8761_CR58","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105:2524\u201339.","journal-title":"Haematologica"},{"key":"8761_CR59","doi-asserted-by":"publisher","first-page":"995","DOI":"10.18632\/oncotarget.953","volume":"4","author":"MJ Ausserlechner","year":"2013","unstructured":"Ausserlechner MJ, Salvador C, Deutschmann A, Bodner M, Viola G, Bortolozzi R, et al. Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa. Oncotarget. 2013;4:995\u20131007.","journal-title":"Oncotarget"},{"key":"8761_CR60","doi-asserted-by":"publisher","first-page":"S222","DOI":"10.3816\/CLM.2009.s.016","volume":"9","author":"D Bhojwani","year":"2009","unstructured":"Bhojwani D, Howard SC, Pui CH. High-risk childhood acute lymphoblastic leukemia. Clin Lymphoma Myeloma. 2009;9:S222\u2013230.","journal-title":"Clin Lymphoma Myeloma"},{"key":"8761_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-105","volume":"13","author":"J Ma","year":"2014","unstructured":"Ma J, Lyu H, Huang J, Liu B. Targeting of erbB3 receptor to overcome resistance in cancer treatment. Mol Cancer. 2014;13:105.","journal-title":"Mol Cancer"},{"key":"8761_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1006636","volume":"13","author":"HC Zheng","year":"2022","unstructured":"Zheng HC, Xue H, Zhang CY, Shi KH, Zhang R. The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis. Front Genet. 2022;13:1006636.","journal-title":"Front Genet"},{"key":"8761_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02271-9","volume":"22","author":"V Tassinari","year":"2021","unstructured":"Tassinari V, Cesarini V, Tomaselli S, Ianniello Z, Silvestris DA, Ginistrelli LC, et al. ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism. Genome Biol. 2021;22:51.","journal-title":"Genome Biol"},{"key":"8761_CR64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molcel.2017.12.006","volume":"69","author":"JF Xiang","year":"2018","unstructured":"Xiang JF, Yang Q, Liu CX, Wu M, Chen LL, Yang L. N(6)-Methyladenosines Modulate A-to-I RNA Editing. Mol Cell. 2018;69:126\u201335 e126.","journal-title":"Mol Cell"},{"key":"8761_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102403","volume":"56","author":"S Saluja","year":"2025","unstructured":"Saluja S, Ganguly S, Singh J, Jain A, Sharma G, Chaudhary S, et al. Aberrant overexpression of m6A writer and reader genes in pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL). Transl Oncol. 2025;56:102403.","journal-title":"Transl Oncol"},{"key":"8761_CR66","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/2643-3230.BCD-21-0160","volume":"3","author":"M Umeda","year":"2022","unstructured":"Umeda M, Ma J, Huang BJ, Hagiwara K, Westover T, Abdelhamed S, et al. Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia. Blood Cancer Discov. 2022;3:194\u2013207.","journal-title":"Blood Cancer Discov"},{"key":"8761_CR67","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"8761_CR68","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"8761_CR69","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, et al. Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Res. 2023;83:3861\u20137.","journal-title":"Cancer Res"},{"key":"8761_CR70","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8761_CR71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08761-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08761-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08761-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:03:06Z","timestamp":1780891386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08761-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8761"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08761-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods presented in this article have been performed in accordance to relevant guidelines and regulations. All experimental work performed on T-ALL cell lines and purchased CD34\n                      +\n                      human cord blood samples and PBMCs (StemCell Technology or AllCells) were performed with approval from the Swedish Ethical Committee (Ethical permission: dnr 2023-07390-02). The RNA-sequencing data including patient material were obtained from the TARGET initiative (phs000218). All patient samples were collected under institutional review board\u2013approved protocols with written informed consent from patients\u2019 parents or legal guardians (\n                      \n                      ). All mouse studies were conducted under protocols approved by the Institutional Animal Care and Use Committee (IACUC, protocol # S23059) of the University of California, San Diego and were in compliance with federal regulations regarding the care and use of laboratory animals: Public Law 99-158, the Health Research Extension Act, and Public Law 99-198, the Animal Welfare Act which is regulated by USDA, APHIS, CFR, Title 9, Parts 1, 2, and 3.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"549"}}